As prostate cancer progresses, androgen metabolism changes ... in CRPC and define how recurrent tumour cells utilise precursor steroids to survive in a low-testosterone (T) environment, a ...
Docetaxel plus prednisone as a first-line chemotherapy ... The identification of new drug resistance mechanisms and prostate cancer molecular subtypes based on genomic and proteomic analysis ...
Hosted on MSN1mon
Symptoms of Prostate CancerTreatment may include steroids, radiation, or surgery. Hypercalcemia: Prostate cancer may result in hypercalcemia (an elevated level of calcium in the blood) due to the breakdown of bone from ...
Men undergoing radiation therapy for prostate cancer who experience side effects early in treatment may face a higher risk of developing more serious long-term urinary and bowel health issues, ...
NICE is unable to make a recommendation about the use in the NHS of niraparib (Zejula) with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer in adults. This ...
A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback